Heavy Drinking Can Damage Every Part of the Eye
WEBJun 24, 2022 · Those who drink heavily can develop peripheral neuropathy, which in turn may decrease corneal sensitivity, masking the real severity of dry eye. Researchers behind that study say their findings “indicate that controlling alcohol consumption may help to reduce [dry eye] prevalence.” 9. Sight-Threatening Diseases.
Cataract Therapy Eye Drop May Reverse Progression
WEBAug 22, 2024 · A cataract therapy eye drop designed to improve visual function in patients with contrast sensitivity (CS) loss due to cataracts is demonstrating that it can also reduce lens density in early phase trials, according to a report published in the American Journal of Ophthalmology.. The cataract therapy drop — referred to as C-KAD — contains an active ingredient, 2.6% ...
Papilledema or Pseudopapilledema? Sharpen Your Image …
WEBFigure 9. These OCT volume scans demonstrate a reduction in the overall volume of the left optic nerve changes at a follow up visit. Less edema is noted in the left after treatment with a unilateral optic nerve sheath fenestration (ONSF) for high grade papilledema in the clinical setting of an afferent pupillary defect and monocular reduction in vision (image on …
Nerve Block for Supraorbital Neuralgia Effective for Both Diagnosis …
WEBJun 17, 2020 · Approximately 8% of subjects in a recent thyroid eye disease study population of 1126 developed symptoms of supraorbital neuralgia, often describing the pain as burning, throbbing, or similar to a nail “driven through the head.”
Diabetic Retinopathy Progression Predictable With UWF …
WEBJul 31, 2024 · Per year of age, NV area overall rose 0.04 mm 2 and increased 0.01 mm 2 in the far periphery. NP area in the mid-periphery was 7.61 mm 2 greater in the left eye than in the right eye.. With each passing year of DR, total NP increased 10.75 mm 2. DR progression was linked with a 78.8 mm 2 rise in NP far-periphery per decade.. Per Early Treatment of Diabetic Retinopathy Study classification ...
Differentiation of Diabetic Retinal Disease vs Other Retinopathies
WEBAug 6, 2021 · Vascular retinopathies, such as diabetic retinopathy (DR) and retinal vein occlusion are common causes of vision loss and blindness in the US and worldwide. Although DR is the most common retinal vascular disease (RVD), not all RVDs are associated with diabetes. Retinal vascular alteration and damage can be secondary to some primary eye conditions, such as retinal telangiectasia in Coats ...
Preservative-Free Glaucoma Drop Option Well Tolerated
WEBAugust 9, 2022. Latanoprost benzalkonium chloride (BAK)-free is efficacious and well tolerated during chronic use, according to recent findings published in Clinical Ophthalmology, providing a nonpreservative option for patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). The phase 3, …
Restoring the Retina: Coming Advancements to Repair Structure …
WEBFeb 16, 2021 · Retinal implants capture light and stimulate secondary neurons that have remained in the retina, such as ganglion cells and bipolar cells, which then send signals to the brain through the optic nerve. “Patients who get a retinal implant will see at least flashes of light,” says Gislin Dagnelie, PhD, associate professor of ophthalmology at ...
A 10-Year Follow-up Affirms AREDS2 with Lutein Still Effective, Safe
WEBJun 21, 2022 · Now, after 10 years, a follow-up analysis demonstrates lutein’s benefit continued without raising the risk for lung cancer, offering assurance for clinicians, as published in JAMA Ophthalmology. In AREDS2, a 5-year clinical trial, patients with intermediate AMD or late AMD in 1 eye were randomized to 4 treatment groups: lutein/zeaxanthin, ω ...
Study Reviews Ahmed Valve Implantation Techniques
WEBIn a retrospective study, researchers investigated Ahmed glaucoma valve implants in patients with neovascular glaucoma between 2010 and 2020 to compare patient outcomes. The study reviewed 2 groups of patients. Group 1 underwent pars plana Ahmed glaucoma valve implant plus pars plana vitrectomy with endolaser. Group 2 …